Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001144204-15-067236

Chief Scientific Officer gave up 39,178 shares (to pay taxes)

  • Chief Scientific Officer acquired 143,247 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

JOHE KARL · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-11-19 Exercise or conversion : show line 1 in the form +143,247 969,551 D
2015-11-19 Shares withheld for taxes : show line 2 in the form −39,178 $1.14 $44,663 930,373 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-11-19 Exercise or conversion : show line 3 in the form Restricted Stock Unit −143,247 0 D
Loading xslF345X03/v425272_4.xml…